Group One Trading
STOK icon

Group One Trading’s Stoke Therapeutics STOK Stock Holding History

Group One Trading’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,110
Closed -$135K – 8696
2025
Q4 		$130K Buy
+4,110
New +$124K ﹤0.01% 4762
2025
Q3 		– Sell
-513
Closed -$8.79K – 9112
2025
Q2 		$5.82K Buy
+513
New +$4.87K ﹤0.01% 7018
2025
Q1 		– Sell
-104,411
Closed -$973K – 8345
2024
Q4 		$1.15M Buy
104,411
+2,637
+3% +$32.4K ﹤0.01% 2444
2024
Q3 		$1.25M Buy
+101,774
New +$1.44M ﹤0.01% 2114
2023
Q2 		– Sell
-236
Closed -$2.51K – 8187
2023
Q1 		$1.97K Sell
236
-664
-74% -$5.99K ﹤0.01% 6619
2022
Q4 		$8.31K Buy
+900
New +$9.36K ﹤0.01% 6102
2022
Q3 		– Sell
-200
Closed -$3.19K – 8226
2022
Q2 		$3K Buy
+200
New +$3.04K ﹤0.01% 7328

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Group One Trading's STOK Position: Q1 2026 in Review

Group One Trading sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 4,110 shares — an estimated $135K sold.

Group One Trading first reported a position in STOK in Q2 2022 and held it in 7 quarters. The position peaked at $1.25M in Q3 2024. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Group One Trading reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4,110 Stoke Therapeutics shares in Q1 2026, an estimated $135K.
  • Group One Trading first reported a position in Stoke Therapeutics in Q2 2022 and held it in 7 quarters.
  • Group One Trading's Stoke Therapeutics position peaked at $1.25M in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.